Send us a text

Approximately 1 in 10 metastatic prostate cancer patients develop osteoporotic fractures.
Whilst treatment for prostate cancer has meant patient are living longer we have to make sure they are also living better.
Testosterone removal, Androgen receptor targeted agents and steroids can all reduce bone strength.

We talk to Dr Xue-Yan Jiang who is part of a group preparing guidelines for bone health through the Royal College of Radiologists and British Association of Urological Surgeons.
We hope you enjoy.

Send us a text

Approximately 15% of all lung cancer happen in non-smokers!!

We talk to Dr Tom Newsom-Davis a medical oncologist who specialises in lung cancer about this very specific group of lung cancers.
Tom is chair-elect of the British Thoracic Oncology Group and shares his experience of treating non-smoking related lung cancers and their driver mutations - EGFR, ROS-1 and ALK.
This is a fascinating discussion and Tom is such an engaging person to talk to.

If you have lungs you can get lung cancer.

Enjoy

John & Mike

Send us a text

In this episode we discuss CDK4/6 inhibitors with Professor Mark Beresford, Clinical oncologist and chair of UK Breast cancer Group.

Mark shares his knowledge on why we are giving these drugs to patients with breast cancer and what patients can expect on them.
This is a really big group of patients and we hope this is useful for supporting them.

We hope you enjoy

John & Mike